from Reuters: Health News https://ift.tt/2XmwWYg
Monday, 1 June 2020
AstraZeneca-Merck Lynparza gets EMA's positive recommendation
Drugmakers AstraZeneca Plc and Merck & Co Inc said on Monday their blockbluster cancer drug, Lynparza, has received positive recommendation from the European Medicines Agency (EMA) as a maintenance treatment for a form of pancreatic cancer.
from Reuters: Health News https://ift.tt/2XmwWYg
from Reuters: Health News https://ift.tt/2XmwWYg
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment